Eli Lilly LATAM News and Activities

Headquarters: Mexico

Eli Lilly LATAM is owned by Eli Lilly.

Eli Lilly is one of the...

Eli Lilly is a company listed under the stock ticker LLY (US).

Eli Lilly has a direct presence in 18 countries.

Eli Lilly has 26 subsidiaries including Adverum Biotechnologies, Akouos and CrossBridge Bio.

They are in:

Acquisition, funding and merger involving Eli Lilly.

Eli Lilly has announced the acquisition of Curevo Vaccine (posted on May 26 2026).
Eli Lilly has announced the acquisition of LimmaTech Biologics (posted on May 26 2026).
Eli Lilly has acquired EngageBio (posted on May 22 2026).
Eli Lilly has acquired Ventyxbio (posted on May 4 2026).
Eli Lilly has announced the acquisition of Ajax Therapeutics (posted on April 28 2026).
Eli Lilly has announced the acquisition of Kelonia Therapeutics (posted on April 20 2026).
Eli Lilly has acquired CrossBridge Bio (posted on April 20 2026).
Eli Lilly has announced the acquisition of Centessa Pharmaceuticals (posted on March 31 2026).
Eli Lilly has announced the acquisition of Orna Therapeutics (posted on February 11 2026).
Eli Lilly has announced the acquisition of Ventyxbio (posted on January 8 2026).
Eli Lilly has acquired Adverum Biotechnologies (posted on December 10 2025).
Adverum Biotechnologies and Eli Lilly have announced they will merge (posted on November 26 2025)..
Eli Lilly has acquired Verve Therapeutics (posted on July 25 2025).
Eli Lilly has announced the acquisition of Verve Therapeutics (posted on June 17 2025).
Eli Lilly has announced the acquisition of SiteOne Therapeutics (posted on May 29 2025).
Eli Lilly has announced the acquisition of Scorpion Therapeutics (posted on January 23 2025).
Eli Lilly has acquired Morphic Therapeutic (posted on August 20 2024).
See more news about Eli Lilly Hide news involving Eli Lilly

View the org chart displaying its 7 main executives

Phelipe Philippsen has joined the company as President of Elli Lilly, Mexico (posted on February 3 2026).

Jean Santana, who was Senior Director, Human Resources Business Partner, Manufacturing and Quality, is promoted to Senior Director, Global People Strategy, Manufacturing and Quality (posted on May 13 2026).
Jasmine Leong, who was Senior Director of International Market Alzheimer's Diagnostics, is promoted to Executive Director, International Brand, Alzheimer (posted on May 4 2026).
Fatemeh Akhlaghi has joined the company as Executive Director, Clinical Pharmacology (posted on May 4 2026).

Create your alert
to follow the executive moves at Eli Lilly LATAM.